Sientra Inc Down 13.74% To $2.61 After Earnings Beat

Friday, August 11, 2023 - Sientra Inc (SIEN) reported upside earnings and downside revenues.

Sientra Inc's earnings came in at an EPS loss of $0.85 per share, 1.00% higher than estimates for an EPS loss of $0.86 per share. The firm's loss per share expanded by 193% since reporting a loss of $0.29 per share a year ago.

Revenues were downbeat at $23.1 million. That is an increase of 7.52% in revenues from the year-ago report and is 6.55% lower than consensus estimates set at $24.8 million.

The stock is down 13.74% to $2.61 after the report.

Sientra Inc's earnings expanded faster than revenues, signaling widening profit margins.

The average recommendation from Wall Street analysts was a Strong Buy which may get revised based on this new data.

InvestorsObserver gives the stock a Bearish Sentiment score at the moment based on recent trading.

Prior to the report, InvestorsObserver gave the stock an overall score of 50. Meanwhile, the average Wall Street analyst rated the stock a Strong Buy.

Sientra Inc is a part of the healthcare sector in the United States. Its business involves the provision of silicone gel breast implants for use in breast augmentation and breast reconstruction procedures. Its operating segments are Breast Products and miraDry. The Breast Products segment focuses on sales of breast implants, tissue expanders and scar management products under the brands OPUS, AlloX2, Dermaspan, Softspan, and BIOCORNEUM. The miraDry segment focuses on sales of the miraDry System and bioTips. Geographically, the firm generates a majority of its revenue from the United States.